Analysts expect Tarsus Pharmaceuticals, Inc. to report revenue of 190.18 M for Q3 26, against a range of 181.37 M to 199.00 M. The most recent reported quarter, Q2 26, came in at 173.91 M, a 1.5% miss against the 176.56 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 48.12 M | 66.41 M | 78.33 M | 102.66 M | 118.70 M | 151.67 M | 162.05 M | 173.91 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 46.04 M | 58.96 M | 72.43 M | 92.29 M | 135.26 M | 144.81 M | 148.39 M | 186.21 M | 199.00 M | 196.47 M | 201.25 M | 235.14 M | 299.96 M | 359.99 M | 249.73 M | 248.02 M | ||||||||||
| Low Estimate | 43.26 M | 51.62 M | 67.45 M | 85.88 M | 110.80 M | 126.78 M | 138.41 M | 166.91 M | 181.37 M | 184.39 M | 175.66 M | 193.30 M | 247.58 M | 297.84 M | 226.16 M | 222.91 M | ||||||||||
| Consensus Estimate | 44.65 M | 55.29 M | 69.94 M | 89.08 M | 123.03 M | 135.80 M | 143.40 M | 176.56 M | 190.18 M | 190.43 M | 188.45 M | 214.22 M | 273.77 M | 328.91 M | 237.95 M | 235.47 M |
Analysts expect Tarsus Pharmaceuticals, Inc. to report earnings per share of -1.45 for Q3 26, against a range of -1.53 to -1.37. The most recent reported quarter, Q2 26, came in at -0.43, a 115.0% miss against the -0.20 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.61 | -0.60 | -0.64 | -0.48 | -0.30 | -0.20 | -0.16 | -0.43 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.90 | -0.69 | -0.68 | -0.34 | -0.34 | -0.08 | -0.38 | -0.19 | -1.37 | -0.08 | -0.18 | 0.21 | -0.65 | 0.28 | 1.09 | 1.36 | ||||||||||
| Low Estimate | -1.04 | -0.75 | -0.74 | -0.38 | -0.40 | -0.08 | -0.44 | -0.21 | -1.53 | -0.10 | -0.22 | 0.19 | -0.73 | 0.24 | 0.89 | 1.12 | ||||||||||
| Consensus Estimate | -0.97 | -0.72 | -0.71 | -0.36 | -0.37 | -0.08 | -0.41 | -0.20 | -1.45 | -0.09 | -0.20 | 0.20 | -0.69 | 0.26 | 0.99 | 1.24 |
Pull Wall Street consensus for Tarsus Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TARS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TARS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TARS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();